Gamida Cell Ltd: Clinical Trials

1 trial sponsored by Gamida Cell Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Gamida Cell Ltd: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Acetaminophen, Biospecimen Collection, Dexamethasone - Multiple Myeloma
Phase 4RecruitingEmory University942025-09-242026-07-23

Conditions studied

Multiple Myeloma (1)

Interventions

4-fluorobenzoyl-Arg-Arg-Nal-Cys-Tyr-Cit-Lys-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2 (S-S bridged) (1)  ·  4-fluorobenzoyl-TN-14003 (1)  ·  Acetaminophen (1)  ·  BKT140 (1)  ·  Blood Component Removal (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Famotidine (1)  ·  Loratadine (1)  ·  Medrol Veriderm (1)  ·  Methylprednisolone (1)  ·  Specimen Handling (1)  ·  auricularum (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)

Countries

United States (1)

Top investigators

Joseph Rimando, MD (1)

NIH funding

P30CA138292 (1)